Vivos (RDGL) Cash from Investing Activities Growth (3y) (2013)
Vivos (RDGL) Cash from Investing Activities Growth (3y) (2013) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -40.94% |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -25.99% |